Loading...
Chemical structure of 2,9-Di(pyridin-4-yl)anthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-1,3,8,10(2H,9H)-tetraone

GB54194

2,9-Di(pyridin-4-yl)anthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-1,3,8,10(2H,9H)-tetraone

Also known as 7,18-dipyridin-4-yl-7,18-diazaheptacyclo[14.6.2.22,5.03,12.04,9.013,23.020,24]hexacosa-1(23),2,4,9,11,13,15,20(24),21,25-decaene-6,8,17,19-tetrone

2,9-Di(pyridin-4-yl)anthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-1,3,8,10(2H,9H)-tetraone (catalogue number GB54194) is a research-grade chemical available from LABO Scientific in Israel, CAS registry number 136847-29-5. Molecular formula C34H16N4O4, molecular weight 544.52. IUPAC name: 7,18-dipyridin-4-yl-7,18-diazaheptacyclo[14.6.2.22,5.03,12.04,9.013,23.020,24]hexacosa-1(23),2,4,9,11,13,15,20(24),21,25-decaene-6,8,17,19-tetrone. Supplied in 2 pack sizes, from 250mg at ₪228.42 to 1g at ₪611.84; the final price is confirmed on your quote, and the lot certificate of analysis and safety data sheet are emailed with your order confirmation.

ChemicalCAS136847-29-5MW544.52FormulaC34H16N4O4
CAS number
136847-29-5
Molecular weight
544.52
Formula
C34H16N4O4
InChIKey
FNHCNEJUZBOMQQ-UHFFFAOYSA-N
Catalogue number
GB54194
Brand
GLPBIO
Computed properties PubChem CID 56845802 · XLogP 4.7 · TPSA 101 Ų · H-bond donors 0
XLogP
4.7
TPSA
101 Ų
H-bond donors
0
H-bond acceptors
6
Rotatable bonds
2
Heavy atoms
42

SMILES C1=CC2=C3C(=CC=C4C3=C1C5=C6C4=CC=C7C6=C(C=C5)C(=O)N(C7=O)C8=CC=NC=C8)C(=O)N(C2=O)C9=CC=NC=C9

Computed descriptors from PubChem (CID 56845802), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.